Image

Intestinal Flora and Metabonomics of Appendicitis

Intestinal Flora and Metabonomics of Appendicitis

Non Recruiting
1-14 years
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to learn about the key bacterial flora and metabolites associated with appendicitis in children. The main questions it aims to answer

are
  • To screen out the key biomarkers of pediatric appendicitis.
  • What are the microbial differences in different parts of pediatric appendicitis patients.

Participants will detect feces using 16s ribosomal RiboNucleicAcid (16S rRNA) gene sequencing technology and differences of the fecal metabolites between healthy children and appendicitis children were analyzed using untargeted metabolomics based on Liquid chromatography-tandem mass spectrometry(LC-M S/MS) platform.Through the analysis of intestinal bacterial flora and metabolomics association and the differential analysis of intestinal bacterial flora in different parts of the case group, the key bacterial flora and metabolites were excavated.

Description

Participants will detect feces using 16s ribosomal RiboNucleicAcid (16S rRNA) gene sequencing technology and differences of the fecal metabolites between healthy children and appendicitis children were analyzed using untargeted metabolomics based on Liquid chromatography-tandem mass spectrometry(LC-M S/MS) platform.

Differences in the intestinal flora of different parts of the case group: the intestinal flora of the case group in feces and rectum were detected by 16s ribosomal RiboNucleicAcid (16S rRNA) gene sequencing technology, and the intestinal flora of different parts were analyzed and compared.

Through the analysis of intestinal bacterial flora and metabolomics association and the differential analysis of intestinal bacterial flora in different parts of the case group, the key bacterial flora and metabolites were excavated.

Eligibility

Inclusion Criteria:

  • Children aged 1-14 years who were initially diagnosed with appendicitis and underwent laparoscopic appendectomy
  • Children aged 1-14 years with non-digestive tract disease and no history of digestive tract disease

Exclusion Criteria:

  • A family history of intestinal disease
  • Allergic to antibiotic therapy drugs
  • Patients with long-term drug use causing microbial structure changes or intestinal flora disorders
  • Patients with other congenital diseases such as Meckel's diverticulum, intestinal rotation and other malrotation
  • With other systemic diseases, such as obvious upper respiratory tract infection or myocarditis
  • Children with other digestive system diseases after auxiliary examination or surgical diagnosis

Study details
    Appendicitis
    Intestinal Metaplasia
    Metabonomics

NCT06035029

HongyiQu

21 October 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.